Pascal Pfister
Nessuna posizione attualmente
Provenienza dei contatti di primo grado di Pascal Pfister
Entità | Tipo di entità | Settore Industriale | |
---|---|---|---|
10
| Public Company | Pharmaceuticals: Major | 10 |
Grafico delle società connesse in secondo grado
Relazione in diverse aziende
Società connesse a Pascal Pfister tramite i suoi contatti personali
Società | Settore | Persone collegate | Posizione principale |
---|---|---|---|
LABCORP HOLDINGS INC. | Medical/Nursing Services | Director/Board Member | |
TRANSGENE | Biotechnology | Director/Board Member Director/Board Member | |
Xequel Bio, Inc.
Xequel Bio, Inc. Pharmaceuticals: MajorHealth Technology Xequel Bio, Inc. operates as a biopharmaceutical company. It develops drugs and medical applications for scar prevention, inflammation reduction, wound healing, and complex tissue regeneration. The company was founded by Gautam Sudhir Ghatnekar in 2005 and is headquartered in Mount Pleasant, SC. | Pharmaceuticals: Major | Chief Executive Officer | |
Nicox Ophthalmics, Inc.
Nicox Ophthalmics, Inc. Pharmaceuticals: MajorHealth Technology Nicox Ophthalmics, Inc. develops ocular diseases treatment products. It offers extensive pipeline such as a number of clinical and pre-clinical programs that principally target ocular allergy, ocular inflammation, and blepharitis. The company was founded by Thomas Cavanagh on December 21, 2007 and is headquartered in Fort Worth, TX. | Pharmaceuticals: Major | Director/Board Member | |
Parke-Davis & Co. Ltd.
Parke-Davis & Co. Ltd. Pharmaceuticals: MajorHealth Technology Part of Pfizer Inc., Parke-Davis & Co. Ltd. is a British pharmaceutical company. The company is based in St. Helier, UK. | Pharmaceuticals: Major | Chief Executive Officer | |
The University of Liverpool
The University of Liverpool Other Consumer ServicesConsumer Services The University of Liverpool operates as a university. It offers post graduate research, foundation courses, continuing and professional development, online study, and doctoral college. The company was founded in 1881 and is headquartered in Liverpool, the United Kingdom. | College/University | Undergraduate Degree | |
IDS | Packaged Software | Chief Executive Officer | |
Bristol-Myers Squibb Pharma Research Labs LLC
Bristol-Myers Squibb Pharma Research Labs LLC Miscellaneous Commercial ServicesCommercial Services Bristol-Myers Squibb Pharma Research Labs LLC researches and develops drugs and related pharmaceutical products. The company is headquartered in San Diego, CA | Miscellaneous Commercial Services | Chief Tech/Sci/R&D Officer | |
EDB Investments Pte Ltd.
EDB Investments Pte Ltd. Investment ManagersFinance EDB Investments Pte Ltd (EDB Investments) is a Venture Capital firm founded in 1991. The firm is headquartered in Singapore. | Investment Managers | Consultant / Advisor | |
Pfizer Group Ltd.
Pfizer Group Ltd. Pharmaceuticals: MajorHealth Technology Part of Pfizer Inc., Pfizer Group Ltd. is a British company that manufactures and sells pharmaceuticals, animal health products, and healthcare products. The company is based in Sandwich, UK. | Pharmaceuticals: Major | President | |
MURO Pharmaceuticals, Inc.
MURO Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Part of RAG-Stiftung, MURO Pharmaceuticals, Inc. manufactures pharmaceuticals, specifically allergy and asthma products. The company is based in Tewksbury, MA. MURO Pharmaceuticals was acquired by ASTA Medica AG on September 30, 1996 for $120.70 million. | Pharmaceuticals: Major | Sales & Marketing | |
OTL Pharma SA
OTL Pharma SA Pharmaceuticals: MajorHealth Technology Part of Kirin Holdings Co., Ltd., OTL Pharma SA is a French company that develops and markets pharmaceutical products in the therapeutic areas of oncology, hematology, neurology, and supportive and intensive care. The company is based in Paris, France. The company was founded by Marc Moguilewsky, Jean-François Labbé, Wim van Bree. OTL Pharma was acquired by Strakan Group Ltd. on January 26, 2004 for $8.92 million. | Pharmaceuticals: Major | Chief Executive Officer | |
University of Massachusetts | College/University | Undergraduate Degree | |
University of Uppsala | College/University | Undergraduate Degree Graduate Degree | |
Trophos SA
Trophos SA Pharmaceuticals: MajorHealth Technology Trophos SA engages in manufacturing and development of pharmaceutical products. It offers medicines to patients with conditions such as amyotrophic lateral sclerosis, spinal muscular atrophy and cardiac ischemia reperfusion injury. The company was founded by Antoine Beret and Michel Delaage in 1991 and is headquartered in Marseille, France. | Pharmaceuticals: Major | Chief Executive Officer | |
École des Hautes Études Commerciales de Paris | College/University | Undergraduate Degree Masters Business Admin | |
France Biotech Association
France Biotech Association Miscellaneous Commercial ServicesCommercial Services France Biotech Association is an independent association founded in 1997 that brings together healthtech entrepreneurs and their expert partners. The non-profit company is based in Paris, France. The association actively contributes to meeting the many challenges of the healthtech industry, such as companies' financing, innovation-related taxes, regulatory and market access related issues. It offers concrete competition and solutions through its commissions and working groups to help startups and SMEs become international leaders capable of rapidly developing and bringing innovative solutions to patients. The French company was founded by Philippe Pouletty, Pascal Brandys, Denis J. Lucquin. | Miscellaneous Commercial Services | Director/Board Member | |
Bausch & Lomb (Australia) Pty Ltd.
Bausch & Lomb (Australia) Pty Ltd. Pharmaceuticals: MajorHealth Technology Bausch & Lomb Australia Pty Ltd. manufactures and distributes prescription medicines. It offers consumer healthcare, prescription, aesthetic skin and eyecare. The company was founded in 2006 and is headquartered in Chatswood, Australia. | Pharmaceuticals: Major | Corporate Officer/Principal | |
TXCELL | Miscellaneous Commercial Services | Chief Executive Officer | |
DEINOVE | Biotechnology | Director/Board Member | |
Pfizer International LLC | Chief Tech/Sci/R&D Officer | ||
Glaxo Wellcome Immobilière de Recherche SA
Glaxo Wellcome Immobilière de Recherche SA Real Estate DevelopmentFinance Glaxo Wellcome Immobilière de Recherche SA provides real estate services. The company was founded in 1992 and is headquartered in Marly-le-Roi, France. | Real Estate Development | Corporate Officer/Principal | |
Kyowa Kirin Ltd.
Kyowa Kirin Ltd. Pharmaceuticals: MajorHealth Technology Founded in 1998, Kyowa Kirin Ltd. is a British pharmaceutical company that develops, manufactures, and distributes pharmaceutical products. Part of Kirin Holdings Co., Ltd., the company is based in London, UK. | Pharmaceuticals: Major | Chief Operating Officer | |
Covadis BV
Covadis BV Packaged SoftwareTechnology Services Covadis BV provides tailor-made software development services. The company is headquartered in Doetinchem, the Netherlands. | Packaged Software | Chairman | |
CIRCIO HOLDING ASA | Biotechnology | Chairman | |
Theralpha | Director/Board Member | ||
Centravet
Centravet Agricultural Commodities/MillingProcess Industries Centravet operates as a veterinary distribution center, which supplies medicine, food and material practitioners and to promote the veterinary surgeon. It offers TransNet, ivet, GmVet, Pilehairs, and Webveto solutions. The company was founded in 1972 and is headquartered in Taden, France. | Agricultural Commodities/Milling | Chairman | |
Loxbridge Research LLP
Loxbridge Research LLP Financial ConglomeratesFinance Loxbridge Research LLP operates as an investment and project management company. It specializes in startup, early stage, and later stage investments in growth stage companies. The firm supports scientists and focuses on sectors like science, medicine and healthcare technology particularly biotech, med-tech, noval therapeutic, diagnostics, cancer, infectious diseases, neurodegeneration, imaging hardware and software, and enabling devices. The company was founded by Charles Roberts in 2008 and is headquartered in London, the United Kingdom. | Financial Conglomerates | Director/Board Member | |
INFANT BACTERIAL THERAPEUTICS AB | Pharmaceuticals: Major | Chief Tech/Sci/R&D Officer Chief Executive Officer | |
NANEXA AB | Medical Specialties | Chairman Director/Board Member | |
Agalimmune Ltd.
Agalimmune Ltd. Pharmaceuticals: MajorHealth Technology Part of BioLineRx Ltd., Agalimmune Ltd. is a British company that develops anti-cancer immunotherapy technology. The company is based in London, UK. The company was founded by Charles Campbell Roberts and Graham Griffiths. The CEO is Mike Westby. Agalimmune was acquired by BioLineRx Ltd. on March 23, 2017 for $6.05 million. | Pharmaceuticals: Major | Director/Board Member | |
Nouscom AG
Nouscom AG Pharmaceuticals: MajorHealth Technology Nouscom AG engages in the development of genetic neoantigen vaccines and oncolytic viruses for prevention and treatment of cancer. Its product pipeline include Nous-209, Nous-PEV, and Nous-THV-001. The company was founded by Alfredo Nicosia, Antonella Folgori, Riccardo Cortese, Stefano Colloca, Cinzia Traboni, Elisa Scarselli, and Gabriella Campadelli in 2007 and is headquartered in Basel, Switzerland. | Pharmaceuticals: Major | Chairman | |
Resolys Bio, Inc.
Resolys Bio, Inc. Miscellaneous Commercial ServicesCommercial Services Resolys Bio, Inc. operates as a pharmaceutical company. The firm develops OSLO and MCC for the treatment of certain forms of traumatic brain injury and chronic painful tissue disorders. The company is headquartered in Delanson, NY. | Miscellaneous Commercial Services | Director/Board Member | |
Eyevance Pharmaceuticals LLC
Eyevance Pharmaceuticals LLC Pharmaceuticals: MajorHealth Technology Eyevance Pharmaceuticals LLC operates as a pharmaceutical company. It develops and commercializes ophthalmic products that enable optimal vision for the patients. The company was founded by Jerry St. Peter and Jason Werner in September 2017 and is headquartered in Forth Worth, TX. | Pharmaceuticals: Major | Founder | |
Algotherapeutix SAS
Algotherapeutix SAS Medical SpecialtiesHealth Technology AlgoTherapeutix SAS is a clinical-stage biotechnology company based in Suresnes, France. The French company is focused on developing targeted, first-in-class therapeutics for peripheral neuropathic pain. Its lead asset, ATX01, is a proprietary topical formulation of amitriptyline that targets the signaling pathways involved in the regulation of pain by inhibiting specific nociceptive sodium channel receptors. The company is currently recruiting patients for a phase II clinical trial of 240 patients for chemotherapy-induced neuropathic pain and a phase II proof of concept trial for erythromelalgia. AlgoTherapeutix has secured FDA fast track development status and orphan drug designation in both the US and EU. AlgoTherapeutix has raised EUR 35 million to date and has a consortium of investors, including Relyens Innovation Santé/Turenne Capital, UI Investissement, and angel investors. The company was founded in 2018 by Olivier Jean Bohuon and Stéphane Thiroloix, with Stéphane Thiroloix serving as the CEO since 2018. | Medical Specialties | Chairman | |
Treehill Partners, LLC | Corporate Officer/Principal | ||
Eyevance Pharmaceuticals Holdings, Inc.
Eyevance Pharmaceuticals Holdings, Inc. Pharmaceuticals: MajorHealth Technology Eyevance Pharmaceuticals Holdings, Inc operates as a holding company through its subsidiaries develops ophthalmic therapies for the ocular surface and anterior segment. The company was founded by Jerry St. Peter and Jason Werner in September 2017 and is headquartered in Fort Worth, TX. | Pharmaceuticals: Major | Chief Executive Officer | |
Nouscom Srl | Miscellaneous Commercial Services | Chairman | |
Orphan Europe SARL
Orphan Europe SARL Pharmaceuticals: MajorHealth Technology Orphan Europe SARL develops and distributes orphan drugs for the treatment of rare diseases. The firm's products include Normosang, Cystagon, Pedea, Carbaglu, Wilzin, Cystadane. The company was founded by William Gunnarsson in 1990 and is headquartered in Puteaux, France. | Pharmaceuticals: Major | Corporate Officer/Principal | |
Astra Research Centre AB | Chairman Chief Tech/Sci/R&D Officer |
Statistiche
Distribuzione geografica
Francia | 18 |
Stati Uniti | 14 |
Regno Unito | 7 |
Svezia | 5 |
Paesi Bassi | 4 |
Settori
Health Technology | 29 |
Commercial Services | 6 |
Consumer Services | 5 |
Finance | 4 |
Technology Services | 3 |
Posizioni
Director/Board Member | 104 |
Chairman | 41 |
Corporate Officer/Principal | 35 |
Chief Executive Officer | 23 |
Independent Dir/Board Member | 20 |
Contatti più connessi
- Borsa valori
- Insiders
- Pascal Pfister
- Connessioni Società